Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
“This is the most common muscle disease in boys, and there is currently no effective therapy,” saidDongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. “This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease.”
Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of a protein known as “dystrophin.” Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. Affected boys lose their ability to walk and breathe as they get older. This places significant limitations on individuals afflicted with the disease. Dystrophin also is one of the largest genes in the human body.
“Due to its size, it is impossible to deliver the entire gene with a gene therapy vector, which is the vehicle that carries the therapeutic gene to the correct site in the body,” Duan said. “Through previous research, we were able to develop a miniature version of this gene called a microgene. This minimized dystrophin protected all muscles in the body of diseased mice.”
However, it took the team more than 10 years to develop a strategy that can safely send the micro-dystrophin to every muscle in a dog that is afflicted by the disease. The dog has a body size similar to that of an affected boy. Success in the dog will set the foundation for human tests.
In this latest study, the MU team demonstrated for the first time that a common virus can deliver the microgene to all muscles in the body of a diseased dog. The dogs were injected with the virus when they were two to three months old and just starting to show signs of DMD. The dogs are now six to seven months old and continue to develop normally.
“The virus we are using is one of the most common viruses; it is also a virus that produces no symptoms in the human body, making this a safe way to spread the dystrophin gene throughout the body,” Duan said. “These dogs develop DMD naturally in a similar manner as humans. It’s important to treat DMD early before the disease does a lot of damage as this therapy has the greatest impact at the early stages in life.”
The Latest on: Muscular Dystrophy
via Google News
The Latest on: Muscular Dystrophy
- Beach outing birthday wish comes true for girl with muscular dystrophy on March 8, 2019 at 11:59 pm
KOTA KINABALU: While most children make friends and find joy in playgrounds, seven-year-old Pearl Amberly's playtimes are mostly in the hospital. This is because Pearl was born with congenital muscula... […]
- Myotonic Muscular Dystrophy Market Share Analysis by Top Key Players, Considering Growth and Demand with Product Type, Application on March 8, 2019 at 10:24 pm
Albany, NY -- (SBWIRE) -- 03/09/2019 -- Myotonic muscular dystrophy (DMD) is a genetic disorder characterized by muscle degeneration and weakness. It is a common form of muscular dystrophy that genera... […]
- International Women’s Day: Three sisters who challenge muscular dystrophy on March 8, 2019 at 12:37 am
Their eyes sparkle with hope and their smiles exude confidence. But neck below, their bodies are incapable of movement. Yet these women have won against a condition that’s rare to face and rarer to fi... […]
- Brisbane brothers with duchenne muscular dystrophy to attempt to climb Mount Kosciuszko on March 7, 2019 at 8:00 pm
Despite having a muscle wasting disease that increasingly keeps them confined to wheelchairs, Oscar and Hugo Williams will climb Australia’s highest mountain. Oscar, 10, and Hugo, 6, of Ferny Hills, w... […]
- Kroger kicks off 2019 Muscular Dystrophy Association fundraising campaign on March 7, 2019 at 11:26 am
Kroger’s Atlanta Division, which includes Georgia, eastern Alabama and South Carolina, kicks off its annual in-store fundraiser for the Muscular Dystrophy Association (MDA). From March 10-25, Kroger c... […]
- Muscular Dystrophy Association and International Association of Fire Fighters Celebrate 65 Years of Fill the Boot Partnership on March 6, 2019 at 12:38 pm
This March, two Virginia fire fighters – Fire Medic, Joe Jarman and Lt. Travis Saunders, with the Suffolk Fire and Rescue Department and Local #2801 are taking Fill the Boot on the road for the March ... […]
- Iowa grocery participates in muscular dystrophy fundraiser on March 2, 2019 at 4:06 pm
BOONE, Iowa (AP) — An Iowa-based grocery store chain is again participating in an annual fundraiser to fight muscular dystrophy, ALS and related muscular degenerative diseases. Fareway Stores througho... […]
- CITGO Contributes Record $14 Million to Muscular Dystrophy Association For Scientific Research and Care During 2018 on March 1, 2019 at 12:00 pm
"We are incredibly grateful for the unparalleled support that CITGO, its employees, and Marketers and Retailers have provided MDA for the past 32 years," said MDA Executive Vice President & Chief Phil... […]
- Parent Project Muscular Dystrophy Leads Duchenne Community to Nation's Capital for Annual Advocacy Conference on March 1, 2019 at 7:22 am
HACKENSACK, N.J., March 1, 2019 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), heads to Washington, ... […]
- Sarepta To Pay $165M To Buy Out Myonexus, Reports Positive Results For Muscular Dystrophy Trial Results on February 27, 2019 at 11:41 am
Sarepta Therapeutics Presents at Limb-Girdle Muscular Dystrophy Type 2E Data Conference (Transcript) (Seeking Alpha) Sarepta said the three clinical trial participants who received MYO-101 at a dose o... […]
via Bing News